Press release
Emerging Trends Influencing The Growth Of The Ovarian Cancer Market: Advancements In AI Platforms For Early Detection Of Ovarian Cancer
Ovarian Cancer
How Big Is the Ovarian Cancer Market Size Expected to Be by 2034?
The market for ovarian cancer has seen a substantial increase in size lately. With an expected rise from $3.67 billion in 2024 to $4.36 billion in 2025, the compound annual growth rate (CAGR) is predicted to be 18.9%. This growth in the past period is credited to an increasing elderly population, a surge in ovarian cancer incidences, a growing prevalence of the disease, increased government initiatives, and escalating healthcare expenditures.
The market size for ovarian cancer is predicted to observe significant expansion in the ensuing years, reaching $8.61 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 18.5%. The growth projected in this period can be accredited to a boost in research focused on personalized medicine and targeted therapies, an escalating elderly population, an increased awareness in healthcare, a surge in cases of ovarian cancer, and growing healthcare costs. Key trends that will shape this period include innovative treatments, progression in radiation therapy, modernized healthcare facilities, technological innovations, and the increased usage of new drugs.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21240
What Are the Emerging Segments Within the Ovarian Cancer Market?
The ovarian cancer market covered in this report is segmented -
1) By Type: Epithelial Ovarian Tumors, Ovarian Germ Cell Tumors, Ovarian Stromal Tumors, Primary Peritoneal Carcinoma
2) By Treatment: Chemotherapy, Targeted Therapy, Radiation Therapy, Immunotherapy, Hormonal Therapy, Surgery
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
4) By End-user: Hospitals, Diagnostic Centers, Drug Stores, Online Pharmacies, Other End Users
Subsegments:
1) By Epithelial Ovarian Tumors: Serous Carcinoma, Mucinous Carcinoma, Endometrioid Carcinoma, Clear Cell Carcinoma, Brenner Tumors
2) By Ovarian Germ Cell Tumors: Dysgerminoma, Teratoma, Yolk Sac Tumor, Embryonal Carcinoma, Choriocarcinoma
3) By Ovarian Stromal Tumors: Granulosa Cell Tumors, Thecomas, Sertoli-Leydig Cell Tumors
4) By Primary Peritoneal Carcinoma: High-Grade Serous Carcinoma, Low-Grade Serous Carcinoma
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21240&type=smp
What Long-Term Drivers Are Shaping Ovarian Cancer Market Trends?
The ovarian cancer market is slated for expansion, driven by the bourgeoning female population. The number of females, whether in a specific region or globally, at any given moment defines the female population. This surge in female population can be attributed to factors such as elevated life expectancy, superior healthcare, and changing demographics. Treatment options for ovarian cancer, including surgery, chemotherapy, targeted therapy, and immunotherapy, aid the female population by eradicating cancerous cells, slowing the progression of the disease, alleviating symptoms, and enhancing survival rates. These treatments contribute to improvinthe quality of life and fostering optimism for more favourable long-term results. As an illustration, in March 2024, the Census Bureau, a US government agency reported the US female population to be approximately 168 million as of July 2022. It also stated that there were roughly 1.9 million additional females aged 85 and above. Furthermore, CEIC Data, a UK-based finance service provider, reported in December 2022 that the number of females aged 15-64 stood at 2,951,856 in 2022, marking an increase from 2,940,645 the prior year. Therefore, the growth of the ovarian cancer market is propelled by the increasing female population.
Who Are the Top Competitors in Key Ovarian Cancer Market Segments?
Major companies operating in the ovarian cancer market are Pfizer Incorporated, Johnson & Johnson Services Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer Aktiengesellschaft, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Boehringer Ingelheim GmbH, Bausch Health Companies Inc., Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Limited, Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Novogen Limited, Oasmia Pharmaceutical AB, Clovis Oncology Inc., Aeterna Zentaris Inc., Allarity Therapeutics Inc., Ellipses Pharma Ltd.
What Are the Major Trends Shaping the Ovarian Cancer Market?
Prominent organizations in the ovarian cancer market are concentrating on sophisticated solutions like AI systems for the precise analysis of intricate medical data. The AI system for ovarian cancer is a technology-enabled structure that utilizes artificial intelligence (AI) and machine learning (ML) to improve diverse facets of ovarian cancer care. Typically, these platforms merge medical imaging, genomic data, electronic health files (EHRs), and real-time analytics to facilitate early diagnosis, personalized treatment strategies, and patient supervision. For example, AIIMS Delhi, in conjunction with CDAC Pune, an Indian entity, pioneered the launch of iOncology.ai in February 2024. This indigenous AI platform, designed for the early detection of breast and ovarian cancer, employs deep learning techniques to accurately interpret radiological and histopathological pictures, aiming to enhance early diagnosis and survival. Integrated into numerous hospitals, iOncology.ai collaborates with the healthcare machinery to offer risk evaluations and endorse mammograms, especially for women in remote areas, forming part of a larger scheme to incorporate AI into healthcare and alleviate the burden on medical systems.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/ovarian-cancer-global-market-report
Which Regions Are Becoming Hubs for Ovarian Cancer Market Innovation?
North America was the largest region in the ovarian cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ovarian cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Ovarian Cancer Market?
2. What is the CAGR expected in the Ovarian Cancer Market?
3. What Are the Key Innovations Transforming the Ovarian Cancer Industry?
4. Which Region Is Leading the Ovarian Cancer Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.
Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emerging Trends Influencing The Growth Of The Ovarian Cancer Market: Advancements In AI Platforms For Early Detection Of Ovarian Cancer here
News-ID: 4069723 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Ovarian
Ovarian Cancer Market Size, Future Trends
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Ovarian Cancer Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key players in…
Polycystic Ovarian Syndrome Treatment Market Report
The findings reviewed by GME stated that the Global Polycystic Ovarian Syndrome Treatment Market will expand with a CAGR value of 5.2 percent from 2021 to 2026. The rising incidence of PCOS increased understanding among a group of patients, and the growing acceptance of standard treatment boosts the PCOS treatment industry growth over the projected timeframe. Furthermore, the research and development of PCOS are predicted to aid in market growth.
Browse…
Ovarian Cancer Drugs Market Report 2020-2030
Forecasts by Therapeutic Class (PARP, PD-L1, Angiogenesis Inhibitors) Plus Analysis of Leading Companies
Download free sample pages: https://www.visiongain.com/report/ovarian-cancer-drugs-market-report-2020-2030/
Ovarian Cancer Drugs Market- our new study reveals trends, R&D progress, and predicted revenues
Where the Ovarian Cancer Drugs is market heading? If you are involved in this industry you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
Discover…
How deadly is Ovarian Cancer?
Ovarian Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025
Ovarian cancer is a cancer that forms in or on an ovary. It results in abnormal cells that have the ability to invade or spread to other parts of the body.
The global Ovarian Cancer Treatment Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025,…
Polycystic Ovarian Syndrome Treatment Market - Regional Analysis
The organic and inorganic strategies by the market players will boost the polycystic ovarian syndrome treatment market. For instance, in 2016, Millendo Therapeutics, Inc., a biopharmaceutical company, entered into an exclusive license agreement with AstraZeneca for the development and commercialization of phase II entered AZD4901, a candidate product for the treatment of polycystic ovarian syndrome. Moreover, in 2017, Astellas Pharma Inc. completed its acquisition of Ogeda SA (formerly Euroscreen S.A.).…
Ovarian Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Ovarian Cancer - Heat Map and Analysis to its growing collection of premium market research reports.
Ovarian Cancer (OC) is the fifth most common malignancy diagnosed in women, and the most common gynecological cancer, with an estimated 225,000 new cases diagnosed globally in 2008. Rates are particularly high in developed countries, and especially in Northern Europe. However, substantial improvements in…
